Related Experiment Videos
Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanoma
Cancer Treatment Reports
|January 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Impact of baseline BMI and weight change in CCTG adjuvant breast cancer trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
CYP2D6 genotype and adjuvant tamoxifen: meta-analysis of heterogeneous study populations.
Clinical pharmacology and therapeutics·2013
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Chemical Composition and Antibacterial Activity of Essential Oils from Different Organs of Pistacia falcata.
Molecules (Basel, Switzerland)·2026
Dietary L-Malic Acid Enhances Growth Performance and Oxidative Myofiber Composition in Nursery Piglets.
Molecules (Basel, Switzerland)·2026
Starch characteristics distinguish malt from non-malt barley and can be modulated via SBEIIb promoter editing.
Frontiers in plant science·2026
Effects of Maca (Lepidium Meyenii) on Sexual Health and libido-A Review.
Journal of dietary supplements·2026